XML 57 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 27, 2014
Sep. 28, 2013
Sep. 27, 2014
Sep. 28, 2013
Net sales $ 404,289 [1] $ 360,013 [1] $ 1,201,543 [1] $ 1,051,265 [1]
Cost of sales 241,909 218,575 730,013 651,985
Gross profit 162,380 141,438 471,530 399,280
Selling and distribution expenses 42,006 41,769 137,078 116,559
General and administrative expenses 40,428 32,181 122,834 112,713
Gain (Loss) Related to Litigation Settlement (6,519) 0 (6,519) 0
Income from operations 86,465 [1] 67,488 [1] 218,137 170,008
Net interest expense and deferred financing amortization, net 3,895 4,249 12,051 11,729
Other (income) expense, net 993 1,394 2,053 1,998
Earnings before income taxes 81,577 61,845 204,033 156,281
Provision for income taxes 21,864 20,903 62,470 52,274
Net earnings 59,713 40,942 141,563 104,007
Net earnings per share:        
Basic (in usd per share) $ 1.05 $ 0.73 $ 2.50 $ 1.87
Diluted (in usd per share) $ 1.05 $ 0.73 $ 2.50 $ 1.86
Weighted average number of shares        
Basic (in shares) 56,866 56,179 56,729 55,706
Dilutive common stock equivalents (in shares) 2 [2] 48 [2] 2 [2] 260 [2]
Diluted (in shares) 56,868 56,227 56,731 55,966
Comprehensive income $ 47,108 $ 47,123 $ 132,372 $ 103,375
[1] Non-operating expenses are not allocated to the operating segments. Non-operating expenses consist of interest expense and deferred financing amortization, foreign exchange gains and losses and other income and expense items outside of income from operations.
[2] There were no anti-dilutive equity awards excluded from common stock equivalents for any period presented.